PSIVIDA CORP

Type: Company
Name: PSIVIDA CORP (pSivida Limited)
First reported 20 hours ago - Updated 12 hours ago - 2 reports

PSIVIDA : Announces ILUVIEN® Receives Marketing Authorization in Norway and Approval for Reimbursement in Portugal

pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development ofsustained release, drug delivery products for treating eye diseases,today announced that ILUVIEN® has been has granted marketingauthorization in Norway for the treatment of vision ... [Published 4 Traders - 20 hours ago]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

Watertown firm expands availability of eye treatment in Europe

PSivida Corp., the Watertown-based maker of eye treatments, has entered the national phase of marketing approval in 10 additional countries in the European Union.PSivida, will soon receive marketing authorizations in Belgium, the Czech Republic, Denmark, ... [Published Business First of Buffalo - Jul 01 2014]
First reported Jun 30 2014 - Updated Jul 01 2014 - 9 reports

Iluvien close to approval in 10 more EU markets

pSivida (ASX:PVA) licensee Alimera Sciences is close to securing marketing authorisations in 10 more European countries for Iluvien in diabetic macular oedema (DMO).Alimera’s application through the EU’s Mutual Recognition Procedure (MRP) has entered ... [Published Australian Life Scientist - Jul 01 2014]
First reported Jun 23 2014 - Updated Jun 24 2014 - 2 reports

Insider Selling: Paul Ashton Sells 7,000 Shares of pSivida Corp Stock (PSDV)

pSivida Corp (NASDAQ:PSDV) CEO Paul Ashton sold 7,000 shares of the company’s stock in a transaction dated Thursday, June 19th. The shares were sold at an average price of $4.00, for a total value of $28,000.00. Following the completion of the sale, the ... [Published American Banking News - Jun 24 2014]
First reported Jun 23 2014 - Updated Jun 24 2014 - 5 reports

Italian Medicines Agency grants marketing authorization to ILUVIEN for chronic DME treatment

pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the Italian Medicines Agency (Agenzia Italiana del Farmaco) has granted marketing authorization ... [Published News-Medical.Net - Jun 23 2014]
First reported May 05 2014 - Updated May 05 2014 - 3 reports

pSivida Presents Preclinical Data Demonstrating Sustained Release of Avastin Using Tethadur at ARVO Annual Meeting

WATERTOWN, Mass.--(EON: Enhanced Online News)--pSivida presents preclinical data demonstrating sustained release of Avastin using Tethadur at ARVO annual meeting ... [Published EON Science - May 05 2014]
Entities: PSIVIDA CORP, Avastin
First reported Apr 01 2014 - Updated Apr 01 2014 - 3 reports

pSivida CEO to Discuss Company’s Sustained Release Delivery System for Biologics at Two Upcoming Conferences

WATERTOWN, Mass.--(EON: Enhanced Online News)--pSivida CEO to discuss Tethadur biologics delivery system technology at two upcoming conferences ... [Published EON Science - Apr 01 2014]
First reported Mar 13 2014 - Updated Mar 13 2014 - 3 reports

pSivida Corp. Announces $7.0 Million Investment by RA Capital

WATERTOWN, Mass.--(EON: Enhanced Online News)--pSivida announces $7 million investment by RA Capital ... [Published EON Science - Mar 13 2014]
Entities: PSIVIDA CORP
First reported Feb 10 2014 - Updated Feb 10 2014 - 11 reports

pSivida Announces ILUVIEN® for DME Accepted by National Health Service Scotland

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces ILUVIEN for DME Accepted by National Health Service Scotland ... [Published EON Environment - Feb 10 2014]
First reported Feb 07 2014 - Updated Feb 07 2014 - 11 reports

pSivida Corp. Reports Second Quarter 2014 Results

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida reports 2nd quarter 2014 results and holds conference call at 4:30 p.m. ET today ... [Published EON Business - Feb 07 2014]
Entities: PSIVIDA CORP
First reported Feb 06 2014 - Updated Feb 06 2014 - 11 reports

pSivida CEO to Present at 16th Annual BioCEO & Investor Conference February 12

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida CEO to present at BioCEO investor conference Feb. 12 - presentation to be webcast ... [Published EON Environment - Feb 06 2014]
Entities: PSIVIDA CORP
First reported Jan 30 2014 - Updated Jan 30 2014 - 10 reports

pSivida Corp Announces Second Quarter 2014 Financial Results Release Date and Conference Call Information

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces second quarter 2014 financial results release date and conference call information ... [Published EON Energy - Jan 30 2014]
Entities: PSIVIDA CORP

Quotes

...Paul Ashton, President and CEO of pSivida. "Additionally, should ILUVIEN be approved by the FDA, we are entitled to a $25 million milestone payment from Alimera in addition to net profit payments on Alimera's sales of ILUVIEN."
pSivida president and chief executive officer Paul Ashton said the acceptance of ILUVIEN for DME by the NHS Scotland is great news. "This follows the November 2013 recommendation of ILUVIEN by the U KU K National Institute for Health and Care Excellence (NICE) as an option for this indication and rapid implementation of the recommendation by the NHS in England" Ashton said...

More Content

All (87) | News (21) | Reports (0) | Blogs (65) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
PSIVIDA : Announces ILUVIEN® Receives Marketing... [Published 4 Traders - 20 hours ago]
pSivida Announces ILUVIEN® Receives Marketing A... [Published Business Wire Health News - 20 hours ago]
Watertown firm expands availability of eye trea... [Published Business First of Buffalo - Jul 01 2014]
Iluvien close to approval in 10 more EU markets [Published Australian Life Scientist - Jul 01 2014]
PSivida Says Iluvien Gets Marketing Authorizati... [Published RTTNews.com - Jun 30 2014]
pSivida Corp. Reports Positive Regulatory Outco... [Published Digital Journal - Jun 30 2014]
pSivida Corp. Reports Positive Regulatory Outco... [Published Nasdaq - Jun 30 2014]
pSivida Corp. Reports Positive Regulatory Outco... [Published Benzinga.com - Jun 30 2014]
pSivida Corp. Reports Positive Regulatory Outco... [Published EON Communications - Jun 30 2014]
pSivida Corp. Reports Positive Regulatory Outco... [Published Market Pulse Navigator - Jun 30 2014]
pSivida Corp. Reports Positive Regulatory Outco... [Published Business Wire Communications News - Jun 30 2014]
pSivida Corp. Reports Positive Regulatory Outco... [Published Business Wire Health News - Jun 30 2014]
pSivida licensee gets Italian approval for Iluvien [Published Australian Life Scientist - Jun 25 2014]
Insider Selling: Paul Ashton Sells 7,000 Shares... [Published American Banking News - Jun 24 2014]
ASPX Awaits Results, BZYR Creating Buzz, CGIX O... [Published RTTNews.com - Jun 24 2014]
Italian Medicines Agency grants marketing autho... [Published News-Medical.Net - Jun 23 2014]
pSivida Corp Announces ILUVIEN?? Receives Marke... [Published BioSpace - Jun 23 2014]
Alimera’s Iluvien is granted marketing authoriz... [Published Pharma Letter - Jun 23 2014]
Insider Selling: pSivida Corp CEO Sells 7,000 S... [Published American Banking News - Jun 23 2014]
pSivida Announces ILUVIEN® Receives Marketing A... [Published Digital Journal - Jun 23 2014]
pSivida Announces ILUVIEN® Receives Marketing A... [Published Business Wire Health News - Jun 23 2014]
pSivida Corp CEO Paul Ashton Unloads 7,000 Shar... [Published American Banking News - Jun 20 2014]
Spear Street Capital Buys Riverworks In Watertown [Published Banker & Tradesman - Jun 20 2014]
Frontrunning: May 14 [Published Zero Hedge - May 14 2014]
pSivida Corp. Reports Third Quarter 2014 Results [Published Business Wire Health News - May 13 2014]
pSivida Presents Preclinical Data Demonstrating... [Published EON Science - May 05 2014]
pSivida Presents Preclinical Data Demonstrating... [Published Business Wire Science: Science News - May 05 2014]
pSivida Presents Preclinical Data Demonstrating... [Published Business Wire Health News - May 05 2014]
pSivida Corp Announces Third Quarter 2014 Finan... [Published Business Wire Health News - May 02 2014]
US EQUITIES OPENING HEADLINES INCLUDING: US equ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 28 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
pSivida Announces ILUVIEN® Receives Marketing A... [Published Business Wire Health News - 20 hours ago]
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces ILUVIEN receives marketing authorization in Norway and approval for reimbursement in Portugal ...
pSivida Corp. Reports Positive Regulatory Outco... [Published EON Communications - Jun 30 2014]
WATERTOWN, Mass.--(EON: Enhanced Online News)--pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the regulatory process for marketing authorizations ...
pSivida Corp. Reports Positive Regulatory Outco... [Published Business Wire Communications News - Jun 30 2014]
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the regulatory process for marketing authorizations in ...
pSivida Corp. Reports Positive Regulatory Outco... [Published Business Wire Health News - Jun 30 2014]
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the regulatory process for marketing authorizations in ...
pSivida Announces ILUVIEN® Receives Marketing A... [Published Business Wire Health News - Jun 23 2014]
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces Iluvien receives marketing authorization in Italy for treatment of chronic diabetic macular edema ...
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.